The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 31, 2016

Filed:

Apr. 10, 2015
Applicant:

Hoffmann-la Roche Inc., Little Falls, NJ (US);

Inventors:

Christine E. Brotherton-Pleiss, Sunnyvale, CA (US);

Zhi Chen, Livingston, NJ (US);

Shawn David Erickson, Leonia, NJ (US);

Kyungjin Kim, Livingston, NJ (US);

Hongju Li, Edison, NJ (US);

Yimin Qian, Wayne, NJ (US);

Sung-Sau So, Verona, NJ (US);

Peter Michael Wovkulich, Apalachin, NY (US);

Lin Yi, Basking Ridge, NJ (US);

Assignee:

Hoffmann-La Roche Inc., Little Falls, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 241/04 (2006.01); C07D 265/30 (2006.01); C07D 279/12 (2006.01); C07D 413/04 (2006.01); C07D 413/06 (2006.01); C07D 413/12 (2006.01);
U.S. Cl.
CPC ...
C07D 413/12 (2013.01); C07D 241/04 (2013.01); C07D 265/30 (2013.01); C07D 279/12 (2013.01); C07D 413/04 (2013.01); C07D 413/06 (2013.01);
Abstract

The invention is concerned with the compounds of formula (I): and pharmaceutically acceptable salts thereof, wherein Y, R1, R2 and R3 are defined in the detailed description and claims. In addition, the present invention relates to methods of manufacturing and using the compounds of formula (I) as well as pharmaceutical compositions containing such compounds. The compounds of formula (I) are antagonists of the TRPA1 channel and may be useful in treating inflammatory diseases and disorders associated with that channel.


Find Patent Forward Citations

Loading…